ASTRAZENECA PLC

About ASTRAZENECA PLC

The Company was formed when the pharmaceutical, agrochemical and specialty chemical businesses of Imperial Chemical Industries PLC were demerged in 1993. In 2000, it demerged the agrochemical business and merged it with the similar business of Novartis to form a new company called Syngenta AG. In 2007, the Group acquired MedImmune, a biologics and vaccines business based in the United States. In 2021, the Group acquired Alexion, a rare disease business based in the United States.

Business information sourced from SEC annual filing filed Feb 24, 2026. Business descriptions reflect the cited filing and may not describe subsequent changes.

Company identification is based on SEC registration information. Financial figures are sourced from SEC filings.

Company information

Registered name

ASTRAZENECA PLC

Ticker symbol

AZN

CIK

0000901832

Exchange

NYSE

Industry

Pharmaceutical Preparations

SEC SIC code

2834

Fiscal year end (MMDD)

1231

Last SEC synchronization

Nov 7, 2026 15:50 UTC

Headquarters / business address

1 FRANCIS CRICK AVENUE
CAMBRIDGE BIOMEDICAL CAMPUS
CAMBRIDGE CB2 0AA

Mailing address

1 FRANCIS CRICK AVENUE
CAMBRIDGE BIOMEDICAL CAMPUS
CAMBRIDGE CB2 0AA

Business phone

011 44 20 7304 5000

Company contact information is drawn from SEC submissions, where reported, and may not reflect current operating locations. Last company information check: Nov 7, 2026 20:22 UTC. Official website, business descriptions and executive details require separate verification.